Comparing bladder-sparing therapies and surgery for recurrent bladder cancer
BEST CARE for Recurrent NMIBC: BladdEr-Sparing Therapy and Cystectomy As TREatments
This study is looking at different treatment options for people with recurring non-muscle invasive bladder cancer to help them and their doctors make better choices about whether to try bladder-sparing therapies or go for surgery, all with the goal of improving their health and quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10856797 on NIH RePORTER |
What this research studies
This research investigates treatment options for patients with recurrent non-muscle invasive bladder cancer (NMIBC), focusing on bladder-sparing therapies versus radical cystectomy. It aims to gather high-quality evidence to guide treatment decisions, as current options are often made with limited information. The study will utilize a unique patient cohort to assess outcomes and help patients, caregivers, and clinicians make informed choices about their care. By addressing the complexities of treatment decision-making, the research seeks to improve patient outcomes and quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with recurrent non-muscle invasive bladder cancer who are facing treatment decisions.
Not a fit: Patients with muscle-invasive bladder cancer or those who have already undergone radical cystectomy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide clearer guidance on the best treatment options for patients with recurrent NMIBC, potentially improving survival rates and quality of life.
How similar studies have performed: Previous research has shown promise in improving treatment decision-making for bladder cancer, but this specific approach is novel and aims to fill significant evidence gaps.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Gore, John L. — University of Washington
- Study coordinator: Gore, John L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.